Arch Venture Management, LLC Kura Oncology, Inc. Transaction History

Arch Venture Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $3.36 Million - $6.32 Million	-206,307 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$7.95 - $18.81 $1.59 Million - $3.76 Million	-200,000 Reduced 49.22%	206,307 $3.36 Million
Q4 2019 Feb 05, 2020	SELL	$12.97 - $15.94 $6.49 Million - $7.97 Million	-500,000 Reduced 55.17%	406,307 $5.59 Million
Q3 2019 Nov 12, 2019	SELL	$14.75 - $20.87 $6.64 Million - $9.39 Million	-450,000 Reduced 33.18%	906,307 $13.7 Million
Q2 2019 Aug 09, 2019	SELL	$14.71 - $19.79 $3.68 Million - $4.95 Million	-250,000 Reduced 15.56%	1,356,307 $26.7 Million
Q1 2019 May 14, 2019	SELL	$13.73 - $16.87 $3.43 Million - $4.22 Million	-250,000 Reduced 13.47%	1,606,307 $0
Q4 2018 Feb 14, 2019	BUY	$10.6 - $17.49 $19.7 Million - $32.5 Million	1,856,307 New	1,856,307 $26.1 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $668M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Arch Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Arch Venture Management, LLC with notifications on news.